// App-Quantinova.ai

PO‐016 : A clinical audit of meropenem usage in a haemato‐oncology population since the introduction of the national antibiotic CQUIN

Researchers

Presenter

  • LMK Pannell

Principal Investigators

  • E Barton

  • DI Marks

Medical Centers

  • Department of Haematology, Bristol Haematology and Oncology Centre

  • Bristol Royal Infirmary, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • N/A

Biomarkers

  • C reactive protein

Drug/Treatment

  • Piperacillin/tazobactam

  • amphotericin b cholesteryl sulfate complex Intravenous

  • Metronidazole

  • Ciprofloxacin

  • amphotericin

  • Piperacillin

  • UK-109496

  • Ceftazidime

  • CL-298741

  • vancomycin capsule

  • Meropenem

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved